The salmon louse (Lepeophtheirus salmonis) is an ectoparasitic copepod with a complex life cycle. It feeds on the mucus, skin and blood of salmonid fish species, causes significant losses in salmon aquaculture. The parasite can persist on the surface of the fish without any effective control being exerted by the host immune system. Given the […]
| Inventor | Institute |
|---|---|
| Abdo Alnabulsi | Vertebrate Antibodies Limited |
| Cat. #: | 158037 |
|---|---|
| Unit size: | 100 ug |
| Research Fields: | Cell biology;Immunology |
| Application: | ELISA ; WB |
| Target: | Sea Louse (Lepeophtheirus salmonis) antigen 2 |
| Reactivity: | Sea Louse |
| Host: | Mouse |
| Class: | Monoclonal |
| Product description: | The salmon louse (Lepeophtheirus salmonis) is an ectoparasitic copepod with a complex life cycle. It feeds on the mucus, skin and blood of salmonid fish species, causes significant losses in salmon aquaculture. The parasite can persist on the surface of the fish without any effective control being exerted by the host immune system. Given the challenges with currently available methods, vaccination appears as an attractive, environmentally sound strategy. The challenge of developing vaccines against ectoparasites arises from the need to understand the complex molecular interactions between vertebrate hosts and ectoparasites, which require the discovery of key pathway molecules that mediate ectoparasite-host interactions. This is a research tool useful in monitoring of sea louse development and host-invasion mechanism. |
|---|---|
| Conjugation: | Unconjugated |
| Isotype: | IgG |
| Molecular weight: | 15 |
| Immunogen: | Ovalbumin-conjugated synthetic peptide |
| Target background: | The salmon louse (Lepeophtheirus salmonis) is an ectoparasitic copepod with a complex life cycle. It feeds on the mucus, skin and blood of salmonid fish species, causes significant losses in salmon aquaculture. The parasite can persist on the surface of the fish without any effective control being exerted by the host immune system. Given the challenges with currently available methods, vaccination appears as an attractive, environmentally sound strategy. The challenge of developing vaccines against ectoparasites arises from the need to understand the complex molecular interactions between vertebrate hosts and ectoparasites, which require the discovery of key pathway molecules that mediate ectoparasite-host interactions. This is a research tool useful in monitoring of sea louse development and host-invasion mechanism. |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151016 | Anti-CyclinA [E72.1] |
Key Info
Anti-CyclinA [E72.1]
|
View Tool | |||||||||||||||||||
| 151019 | Anti-Mos [S3.1] |
Key Info
Anti-Mos [S3.1]
|
View Tool | |||||||||||||||||||
| 151023 | Anti-IL12 [1-1D5] |
Key Info
Anti-IL12 [1-1D5]
|
View Tool | |||||||||||||||||||
| 151026 | Anti-FCGR1 [10.1] mAb |
Key Info
Anti-FCGR1 [10.1] mAb
|
View Tool | |||||||||||||||||||
| 151040 | Anti-CD11 & CD18 [24] |
Key Info
Anti-CD11 & CD18 [24]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.